PFIZER HAS STRONG MANAGED CARE PENETRATION, COMPANY TELLS BAIRD INVESTMENT CONFERENCE; ENABLEX FDA ADVISORY COMMITTEE REVIEW FOR ARTHRITIS NEARING
Executive Summary
Pfizer's aggressive promotion to managed care has "earned strong acceptance" of its products on managed care formularies, Pfizer VP-Investor Relations James Gardner, PhD, told the R.W. Baird Healthcare Conference in Chicago Aug. 10.